On Sept. 25, 2015, the U.S. Pharmacopeial Convention (USP) Compounding Expert Committee pre-posted revisions to General Chapter 797 Pharmaceutical Compounding – Sterile Preparations for public comment. The purpose of these revisions is to clarify requirements, reflect stakeholder feedback, and incorporate new information. The proposed revisions will be published for public comment in Pharmacopeial Forum (PF) 41(6) [Nov.–Dec. 2015] on Nov. 2, 2015.
The USP will hold an open microphone web meeting on Wednesday, Oct. 21, 2015 at 2 p.m. ET to discuss the proposed revisions.
More information about the proposed revisions and how to submit public comments can be found on the USP website.
The proposed revisions with line numbers can be viewed
.
Registration information for the open microphone meeting can be found here.
Source: CDC
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.